Skin toxicity after Filgrastim treatment for an Ewing's sarcoma patient.

Issad Nefzi Yosra YahyaouiFeriel LetaiefNour GhammemAzza GabsiMouna AyadiAmel Mezlini

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

The cutaneous reaction that has reported with use of GSCF are sweet syndrome, erythema nodosum, pyoderma nodosum and pyoderma gangrenosum. As far as we know, no acute generalized exanthematous pustulosis due to GSCF has been reported

Keyphrases

case report
liver failure
respiratory failure
oxidative stress
combination therapy
aortic dissection
hepatitis b virus
replacement therapy
chemotherapy induced